Chris Williams, Ph.D.

Dr. Williams received his Ph.D. in Biochemistry from the Ohio State University in 1992. Although his research and dissertation were focused on mathematical methods to enhance Fourier Transform Mass Spectrometry, most of the past decade he worked in the area of human genetic and metabolic screening for the world's leading life sciences company in the area of newborn screening. Williams developed and implemented software used in dozens of laboratories worldwide to acquire and analyze mass spectral data in order to identify babies with treatable genetic disorders.

For more than twenty years, though, Dr. Williams has been concerned about human genetic damage caused by radiocarbon, and its implications for cancer, birth defects, and aging. This led to his decision in 2005 to patent targeted methods to reduce this damage, and to then devote full time to developing these methods starting in early 2007.